The substance a lab found at a prohibited level in Justify after he won the 2018 Santa Anita Derby (G1), scopolamine, has seen plenty of attention from regulators in recent years.

O’Neill-trained runners Legends of War and Stubbins finished 1-2 in the $497,500 Nevada State Bank Franklin-Simpson Stakes (G3) Sept. 12, generating a handsome reward for his stable and those that backed his runners.

The 5-year-old son of Sea The Stars had successful surgery

Bruno Schickedanz’s homebred Elite Song scored a 6 3/4-length maiden win on debut Sept. 11 at Woodbine to become the first winner for freshman sire Katz My Song.

The document highlights the company’s recent achievements toward philanthropy, industry leadership, property development and innovation, while fulfilling its core mandate of sustaining the horse racing industry.

Godolphin’s group 1 winner Old Persian is set to make his North American race debut Sept. 14 in the $300,000 Northern Dancer Turf Stakes (G1T), a 1 1/2-mile marathon for 3-year-olds and up on Woodbine’s E.P. Taylor Turf Course.

Some connections of Justify reacted Sept. 12 to a New York Times story revealing that the eventual Triple Crown winner failed a post-race drug test following his 2018 Santa Anita Derby (G1) victory by saying contamination caused the positive test.

Starship Jubilee seeks a repeat in the Canadian Stakes Presented by the Japan Racing Association (G2T) and Pink Lloyd headlines the Bold Venture Stakes (G3) on the Ricoh Woodbine Mile Stake (G1T) undercard Sept. 14 at Woodbine.